NEWS

News from the PAASP network
Great distinction for PAASP partner Martin C. Michel
December 18, 2020

Martin – once again – made it into the Clarivate List of Highly Cited Researchers 2020. This list recognizes true pioneers in…

Read More
The BioRN annual conference
December 18, 2020

The BIOtech network Rhein-Neckar (BioRN) held its annual (digitally) conference virtually on November 20th. The network brings together a mix of…

Read More
New publication co-authored by PAASP: Survey of Core Facilities shows the importance of communication and management for optimal research quality
December 18, 2020

PAASP and the Interdisciplinary Neurobehavioral Core (INBC) at the University of Heidelberg aim to establish a quality framework for Core Facilities…

Read More
PAASP publication in Nature Reviews Drug Discovery: Improving target assessment in biomedical research – the GOT-IT recommendations
December 18, 2020

The PAASP team has published an article in Nature Reviews Drug Discovery, together with research groups from the Fraunhofer IME-TMP and the…

Read More
Guidelines for target validation published
November 16, 2020

The GOT-IT team, consisting of researchers from the Fraunhofer Institute, Charité and PAASP, announces the publication of their guidelines for target validation…

Read More
PAASP Editorial in the Journal Temperature
October 8, 2020

Please following this LINK to our Editorial “Enhancing quality in preclinical data: Of hot science and cool quality”, which was just published in…

Read More
EQIPD: PAASP’s contribution to the new Quality System for preclinical research
October 8, 2020

EQIPD (European Quality In Preclinical Data) is a project that was funded by the Innovative Medicine Initiative with the vision to enable a…

Read More
PEERS – the Platform for the Exchange of Experimental Research Standards
October 8, 2020

We are happy to announce that PAASP is part of the PEERS (Platform for the Exchange of Experimental Research Standards) initiative, which is supported by…

Read More
Research rigor in preclinical studies on biological effects of whole-body exposure to electromagnetic fields (2G/3G cell phone technology)
May 26, 2020

Various modern technologies are known to bear risks to the human health. In many cases, the society learns about these risks…

Read More
Data analysis – Issues, challenges and solutions
March 31, 2020

The first official meeting of the Preclinical Data Forum took place in Berlin in 2014 and one of the central seminars was given…

Read More
New Author Guidelines for Displaying Data and Reporting Data Analysis and Statistical Methods in Experimental Biology
February 1, 2020

To improve the robustness and transparency of scientific reporting, the American Society for Pharmacology and Experimental Therapeutics (ASPET), with input from PAASP’s Martin…

Read More
PAASP US, LLC receives funding from NIH
January 29, 2020

The PAASP Network is very glad to announce that the NIH has awarded an SBIR grant to a Network member –…

Read More
PAASP at the REWARD/EQUATOR Conference in Berlin (February 20-22, 2020)
December 18, 2019

We will present our activities to improve Good Research Practice and Data Quality and are very much looking forward to meet…

Read More
PAASP signed the DORA Declaration
December 11, 2019

The Declaration on Research Assessment (DORA) recognizes the need to improve the ways in which the outputs of scholarly research are…

Read More
News from NIDA
November 22, 2019

The National Institute on Drug Abuse (NIDA), part of the US National Institutes of Health (NIH), is pleased to announce an…

Read More
Presentation of the newly developed Guidelines On Target Validation for Innovative Therapeutics (GOT-IT)
November 22, 2019

Representing the GOT-IT Team, Christoph Emmerich presented the GOT-IT Guidelines at the “BMBF Vernetzungstreffen zur Nationalen Wirkstoffinitiative” on the 8th of October…

Read More
PAASP US: Poster presentation at the Milken Institute
November 21, 2019

The Milken Institute Future of Health Summit (Oct 28-30, 2019) was recently held in Washington D.C. (USA) and brought together thought leaders and…

Read More
New members of the PAASP Advisory Board
May 22, 2019

We are delighted to announce that Dr. Rita Balice-Gordon and Dr. Phil Skolnick have joined PAASP’s Advisory Board:Rita Balice-Gordon, Ph.D., is…

Read More
Thank you, Bruce! Welcome, Glenn!
March 11, 2019

As many of our readers already know, our dear colleague and advisor, Bruce Altevogt, moved on to take a new and…

Read More
The US team has won the 6th NIH/NIDA Challenge Award
March 11, 2019

In December 2018, the National Institute on Drug Abuse (NIDA) initiated its sixth annual Challenge competition with the aim to solicit…

Read More
PAASP moves across the Atlantic!
March 11, 2019

We have always enjoyed our connections to peers in the US and the support from our US-based advisors, but have felt…

Read More
PAASP moves into new offices
December 20, 2018

In January 2019, we are moving into new office space, located in the centre of Heidelberg (Kunsthaus 25, Hauptstraße 25, 69117…

Read More
PAASP’s ‘Data Quality’ workshop at HBIGS
November 17, 2018

PAASP’s ‘Data Quality’ workshop at the Heidelberg Biosciences International Graduate School (HBIGS) Recognizing the lack of educational courses for students, postdocs…

Read More
PAASP enters a new partnership with HENRICH Pharma-R&D Consulting
July 20, 2018

We are proud to announce that PAASP has partnered with HENRICH Pharma-R&D Consulting, a specialised consulting firm located in the Frankfurt…

Read More
PAASP’s ‘Data Quality’ workshop at the Justus-Liebig-University Gießen
February 27, 2018

PAASP Partner Prof. Martin Michel led a two-day workshop at the Giessen Graduate Centre for the Life Sciences (GGL). Together with…

Read More
PAASP is part of the BMBF-funded GOT-IT (‘Guidelines On Target Validation for Innovative Therapeutics’) Project
January 23, 2018

Medical progress and continued supply of innovative medicines can only be guaranteed by continuous research and development of new active drugs…

Read More
Meeting Report – St. Petersburg:
June 7, 2017

June 1, 2016 – Anton Bespalov participated in the meeting “Current issues in the preclinical and clinical research on novel drugs,…

Read More
PAASP partner became TÜV-certified ‘Qualitätsbeauftragter, -manager and -auditor’
May 7, 2017

PAASP partner Björn Gerlach undertook a three-month course focusing on classical quality management systems, like ISO9001 and EFQM. After passing written…

Read More
Re-evaluation of failed drugs and targets using contemporary knowledge, methodology and tools
July 22, 2016

Co-authored by PAASP’s managing partner, Anton Bespalov, the correspondence article ‘Failed trials for central nervous system disorders do not necessarily invalidate…

Read More
Building a nearshoring collaboration: Success story
May 30, 2016

Starting to work together with someone you do not know is often associated with some risk-taking if this person is outside…

Read More
PAASP enters a new partnership with Arlenda
May 22, 2016

Various aspects of the service provided by PAASP are directly or indirectly related to data analysis. While the PAASP team has…

Read More
Y47 Partnership
April 22, 2016

PAASP services aim to identify areas that need improvement and to provide our clients with the necessary tools. We believe that…

Read More
DGGF Membership
March 20, 2016

DGGF Membership PAASP became a member of the DGGF (Deutsche Gesellschaft für Gute Forschungspraxis; German Society for Good Research Practice). The DGGF is…

Read More
The Wheel of Science
February 20, 2016

You might have seen the Wheel of Science (WoS) on the front page of our website – but what does it actually mean…

Read More
PAASP: current and future activities
February 20, 2016

PAASP was founded with the mission to ‘protect the integrity of science, increase reproducibility and ensure proper training of new generations…

Read More
Introducing PAASP: Why not a non-profit organisation?
February 20, 2016

We, Anton Bespalov, Björn Gerlach and Christoph Emmerich, the three co-founders of PAASP, all reside in Germany and we have carefully…

Read More